← All companies

EMMA

Emmaus Life Sciences, Inc.

EMMA OTC Pharmaceutical Preparations EDGAR ↗

$0.01

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$702K

Revenue (TTM)

$12.0M

Net income (TTM)

-$8.50M

EPS (TTM)

$-0.13

P/E ratio

—

Dividend yield

-500.00%

Free cash flow

-$12.0K

Cash

$1.07M

Total assets

$18.7M

Gross margin

93.3%

52-week range

$0.01 – $0.02

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Results of operations (earnings release) May 15, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Director or officer change Apr 17, 2026 8-K Director or officer change Apr 14, 2026 8-K Results of operations (earnings release) Mar 31, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Entered a material agreement Mar 4, 2026 8-K Entered a material agreement; Other events Dec 31, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Dec 22, 2025 8-K Director or officer change Dec 19, 2025 8-K Results of operations (earnings release) Nov 14, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Director or officer change Jul 1, 2025 8-K Results of operations (earnings release) May 15, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Changed accountants May 6, 2025 8-K Results of operations (earnings release) Apr 14, 2025 10-K Fiscal year ended 2024-12-31 Apr 14, 2025 8-K Results of operations (earnings release) Nov 19, 2024 10-Q Quarter ended 2024-09-30 Nov 19, 2024 8-K Director or officer change Nov 6, 2024 8-K Changed accountants Oct 25, 2024 8-K Director or officer change Oct 4, 2024 8-K Results of operations (earnings release); Changed accountants Sep 10, 2024 10-Q Quarter ended 2024-06-30 Sep 10, 2024 10-Q Quarter ended 2024-03-31 Sep 10, 2024 8-K Director or officer change Jul 17, 2024 8-K Results of operations (earnings release) Jul 3, 2024 10-K Fiscal year ended 2023-12-31 Jul 3, 2024 8-K Amended charter or bylaws May 28, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Feb 26, 2024 8-K Entered a material agreement; Unregistered sale of equity Dec 20, 2023 8-K Results of operations (earnings release) Nov 14, 2023 10-Q Quarter ended 2023-09-30 Nov 14, 2023 8-K Director or officer change Oct 4, 2023 8-K Director or officer change Aug 23, 2023 8-K Results of operations (earnings release) Aug 14, 2023 10-Q Quarter ended 2023-06-30 Aug 14, 2023